Is PCOD a serious problem? Can it lead to cancer?

Note on the name: in May 2026, polycystic ovary syndrome (PCOS) was formally renamed polyendocrine metabolic ovarian syndrome (PMOS), following a global consensus process. The old name was inaccurate — the condition affects multiple hormone and metabolic systems, not just the ovaries, and "polycystic" wrongly implies ovarian cysts. Nothing about the condition, its diagnosis or its treatment has changed. Both names will be used side by side for the next few years, and we use PCOS below since that is the term most people know.

PCOS is a condition to manage rather than to fear, and for most women with reasonable care it does not lead to cancer. The specific risk is endometrial cancer, and the mechanism is worth understanding because it tells you how to prevent it. When ovulation does not happen, the lining is exposed to oestrogen without the progesterone that normally opposes it. Over years, that unopposed exposure can lead to hyperplasia and, uncommonly, to cancer. The protective step is simply ensuring the lining sheds periodically — through restored ovulation with weight management, or with prescribed hormonal treatment. As a rough guide, going more than three or four months at a time without a period is worth discussing with your gynaecologist. The other long-term risks are metabolic: type 2 diabetes, high cholesterol, high blood pressure, and fatty liver disease. These are more likely to affect you than cancer, and they respond to the same measures. So yes, PCOS deserves proper attention — but the risks are largely preventable, and knowing which they are makes the management straightforward.